- Home
- ORIC vs EQBK Comparison
ORIC vs EQBK Comparison
Compare ORIC & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- EQBK
- Stock Information
- Founded
- ORIC 2014
- EQBK 2002
- Country
- ORIC United States
- EQBK United States
- Employees
- ORIC N/A
- EQBK N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- ORIC Health Care
- EQBK Finance
- Exchange
- ORIC Nasdaq
- EQBK Nasdaq
- Market Cap
- ORIC 633.7M
- EQBK 750.4M
- IPO Year
- ORIC 2020
- EQBK 2015
- Fundamental
- Price
- ORIC $9.58
- EQBK $43.12
- Analyst Decision
- ORIC Strong Buy
- EQBK Hold
- Analyst Count
- ORIC 9
- EQBK 4
- Target Price
- ORIC $18.75
- EQBK $44.50
- AVG Volume (30 Days)
- ORIC 597.6K
- EQBK 84.6K
- Earning Date
- ORIC 03-10-2025
- EQBK 01-22-2025
- Dividend Yield
- ORIC N/A
- EQBK 1.25%
- EPS Growth
- ORIC N/A
- EQBK N/A
- EPS
- ORIC N/A
- EQBK 1.12
- Revenue
- ORIC N/A
- EQBK $157,755,000.00
- Revenue This Year
- ORIC N/A
- EQBK N/A
- Revenue Next Year
- ORIC N/A
- EQBK $6.05
- P/E Ratio
- ORIC N/A
- EQBK $38.46
- Revenue Growth
- ORIC N/A
- EQBK N/A
- 52 Week Low
- ORIC $6.33
- EQBK $30.44
- 52 Week High
- ORIC $16.65
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- ORIC 54.79
- EQBK 50.11
- Support Level
- ORIC $7.86
- EQBK $39.26
- Resistance Level
- ORIC $11.15
- EQBK $43.27
- Average True Range (ATR)
- ORIC 0.72
- EQBK 1.07
- MACD
- ORIC 0.23
- EQBK 0.28
- Stochastic Oscillator
- ORIC 52.28
- EQBK 85.02
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.